世界科学技术-中医药现代化
世界科學技術-中醫藥現代化
세계과학기술-중의약현대화
WORLD SCIENCE AND TECHNOLOGY-MODERNIZATION OF TRADITIONAL CHINESE MEDICINE
2014年
2期
239-248
,共10页
刘秋燕%吕光耀%张春兰%张淑芳
劉鞦燕%呂光耀%張春蘭%張淑芳
류추연%려광요%장춘란%장숙방
天麻钩藤饮%眩晕%随机对照试验%系统评价%Meta分析
天痳鉤籐飲%眩暈%隨機對照試驗%繫統評價%Meta分析
천마구등음%현훈%수궤대조시험%계통평개%Meta분석
Tian-Ma Gou-Teng Decoction%vertigo%randomized controlled trial%systematic review%meta-analysis
目的:系统、全面评价天麻钩藤饮治疗眩晕的临床有效率和安全性。方法:计算机检索中国期刊全文数据库、重庆维普中文科技期刊数据库、中国知网数据库、中国生物医学文献数据库网络版、万方数据库和中国中医药期刊文献数据库,查找天麻钩藤饮治疗眩晕的随机对照试验,检索时限均从建库至2013年3月31日。由2名研究者按照纳入与排除标准独立进行文献筛选、资料提取和质量评价后,采用RevMan5.0.2软件进行Meta分析。结果:共计纳入33项试验,涉及2922例眩晕患者。Meta分析结果显示,在临床有效性方面,中医治疗组与西医治疗组对比(OR=3.67,95豫CI[2.66~5.07])、中西医治疗组与西医治疗组对比(OR=3.28,95豫CI[2.33~4.62]),中医联合其他方法(如针灸、推拿)治疗组与中医其他方法治疗组对比(OR=2.29,95豫CI[1.34~3.91]),试验组疗效均优于对照组;在复发率方面,天麻钩藤饮治疗眩晕与对照组相比(OR=0.27,95豫 CI[0.12~0.65]),天麻组优于对照组;在不良反应方面,天麻钩藤饮治疗眩晕与对照组相比(OR=0.40,95豫 CI[0.13~1.24])天麻组优于对照组;其他指标如生活质量,由于并没有完全报道的文献,未能进行下一步的分析。结论:本系统评价结果显示,与其他方法相对比,天麻钩藤饮治疗眩晕具有更好的临床有效率,且复发率较低,但安全性有待进一步评价。由于纳入研究的文献质量不高,当前证据尚不能确定完全适用于临床,但其疗效优势值得进一步研究,特别需要高质量的多中心、大样本及双盲的随机对照试验加以验证。
目的:繫統、全麵評價天痳鉤籐飲治療眩暈的臨床有效率和安全性。方法:計算機檢索中國期刊全文數據庫、重慶維普中文科技期刊數據庫、中國知網數據庫、中國生物醫學文獻數據庫網絡版、萬方數據庫和中國中醫藥期刊文獻數據庫,查找天痳鉤籐飲治療眩暈的隨機對照試驗,檢索時限均從建庫至2013年3月31日。由2名研究者按照納入與排除標準獨立進行文獻篩選、資料提取和質量評價後,採用RevMan5.0.2軟件進行Meta分析。結果:共計納入33項試驗,涉及2922例眩暈患者。Meta分析結果顯示,在臨床有效性方麵,中醫治療組與西醫治療組對比(OR=3.67,95豫CI[2.66~5.07])、中西醫治療組與西醫治療組對比(OR=3.28,95豫CI[2.33~4.62]),中醫聯閤其他方法(如針灸、推拿)治療組與中醫其他方法治療組對比(OR=2.29,95豫CI[1.34~3.91]),試驗組療效均優于對照組;在複髮率方麵,天痳鉤籐飲治療眩暈與對照組相比(OR=0.27,95豫 CI[0.12~0.65]),天痳組優于對照組;在不良反應方麵,天痳鉤籐飲治療眩暈與對照組相比(OR=0.40,95豫 CI[0.13~1.24])天痳組優于對照組;其他指標如生活質量,由于併沒有完全報道的文獻,未能進行下一步的分析。結論:本繫統評價結果顯示,與其他方法相對比,天痳鉤籐飲治療眩暈具有更好的臨床有效率,且複髮率較低,但安全性有待進一步評價。由于納入研究的文獻質量不高,噹前證據尚不能確定完全適用于臨床,但其療效優勢值得進一步研究,特彆需要高質量的多中心、大樣本及雙盲的隨機對照試驗加以驗證。
목적:계통、전면평개천마구등음치료현훈적림상유효솔화안전성。방법:계산궤검색중국기간전문수거고、중경유보중문과기기간수거고、중국지망수거고、중국생물의학문헌수거고망락판、만방수거고화중국중의약기간문헌수거고,사조천마구등음치료현훈적수궤대조시험,검색시한균종건고지2013년3월31일。유2명연구자안조납입여배제표준독립진행문헌사선、자료제취화질량평개후,채용RevMan5.0.2연건진행Meta분석。결과:공계납입33항시험,섭급2922례현훈환자。Meta분석결과현시,재림상유효성방면,중의치료조여서의치료조대비(OR=3.67,95예CI[2.66~5.07])、중서의치료조여서의치료조대비(OR=3.28,95예CI[2.33~4.62]),중의연합기타방법(여침구、추나)치료조여중의기타방법치료조대비(OR=2.29,95예CI[1.34~3.91]),시험조료효균우우대조조;재복발솔방면,천마구등음치료현훈여대조조상비(OR=0.27,95예 CI[0.12~0.65]),천마조우우대조조;재불량반응방면,천마구등음치료현훈여대조조상비(OR=0.40,95예 CI[0.13~1.24])천마조우우대조조;기타지표여생활질량,유우병몰유완전보도적문헌,미능진행하일보적분석。결론:본계통평개결과현시,여기타방법상대비,천마구등음치료현훈구유경호적림상유효솔,차복발솔교저,단안전성유대진일보평개。유우납입연구적문헌질량불고,당전증거상불능학정완전괄용우림상,단기료효우세치득진일보연구,특별수요고질량적다중심、대양본급쌍맹적수궤대조시험가이험증。
This study was aimed to make a systematic and comprehensive evaluation on clinical efficacy and safety of vertigo treatment with Tian-Ma Gou-Teng (TMGT) Decoction. Articles had been searched in the Chinese Journal Full-text Database, Chongqing VIP Chinese Scientific Journals Database, China National Knowledge Infrastructure (CNKI), Chinese Biomedical Literature Database Online, Wanfang Data and Chinese Medicine Journal Literature Database for randomized controlled trials (RCT) on vertigo treatment with TMGT Decoction. The data retrieval time was from the establishment time of the database until present. Two investigators screened literatures, extracted data and assessed quality according to inclusion and exclusion criteria independently. RevMan5.0.2 was used in the meta-analysis. The results showed that a total of 33 trials were involved, which covered 2922 vertigo cases. The meta-analysis showed that from the aspect of clinical effectiveness, the comparison between Chinese medicine treatment group and modern medicine treatment group (OR = 3.67, 95% CI [2.66~5.07]), comparison between integrative medicine treatment group and modern medicine treatment group (OR = 3.28, 95% CI [2.33~4.62]), the comparison between Chinese medicine combined with other method (such as acupuncture, Tuina) treatment group and other Chinese medicine treatment group (OR = 2.29, 95% CI [1.34~3.91]), therapeutic effect in the experimental group was better than the control group. For the aspect of relapse rate, TMGT Decoction in the treatment of vertigo was better than the control group (OR = 0.27, 95% CI [0.12~0.65]). In the aspect of adverse reactions, TMGT Decoction in the treatment of vertigo was better than the control group (OR = 0.40, 95% CI [0.13~1.24]). For aspects of other indicators such as quality of life, no further analysis was conducted since there was no complete reported literature. It was concluded that the system evaluation results showed that compared with other methods, TMGT Decoction has better clinical efficacy and low recurrence rate, but safety needs to be further eualuated. However, due to the quality of included studies was not high, current evidences cannot be determined to be fully applicable in the clinical practice. But its efficacy advantages are worthy of further research. It especially requires high quality multi-center, large sample, double-blind, RCTs to verify.